Nitric Oxide Plasma Level as a Barometer of Endothelial Dysfunction in Factory Workers

Abstract

Objective Nitric oxide (NO) plays a key role in the regulation of vascular tone and is known as one of the key markers of endothelial dysfunction. We investigated the relationship between NO and risk factors of lifestyle-related disease in factory workers.

Methods Our study included 877 factory workers presenting hypertension, dyslipidemia and type 2 diabetes. Oxidated forms of NO, NO2-/NO3- (NOx) plasma concentrations were measured using a colorimetric method.

Results NOx plasma levels in patients with lifestyle-related disease were significantly lower than those in the controls. The brachial-ankle pulse wave velocity (baPWV) measured in those patients was significantly greater than that of the controls. Multiple regression analysis revealed that LDL cholesterol was an independent risk factor for reducing NOx plasma concentrations. Interestingly, individuals with low NOx plasma concentrations were more likely to present type 2 diabetes compared to those with the highest plasma levels of NOx (odds ratio [OR] [95% confidence interval; CI]=3.65 [1.61–8.28], P=0.002, 2.67 [1.15–6.20], P=0.022, and 3.27 [1.43–7.48], P=0.005). Subjects with the lowest levels of plasma NOx were more likely to present dyslipidemia (OR [95% CI]=1.69 [1.13–2.53], P=0.01).

Conclusion Endothelial function evaluated with plasma NOx may be indicative of lifestyle-related diseases independently from the vascular function assessed using baPWV.

Key words

nitric oxide - pulse wave velocity - hypertension - dyslipidemia - type 2 diabetes

• References

• 1 World Health Organization. The top 10 causes of death.http://who.int/mediacentre/factsheets/fs310/en/ 2014; accessed 9 May 2016
• 2 D’Agostino RB, Grundy S, Sullivan LM. et al. Validation of the Framingham coronary heart disease prediction scores: Results of a multiple ethnic groups investigation. JAMA 2001; 286: 180-187
• 3 Conroy RM, Pyörälä K, Fitzgerald AP. et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: The SCORE project. Eur Heart J 2003; 24: 987-1003
• 4 Ford E, Ajani UA, Croft JB. et al. Explaining the Decrease in U.S. Deaths from Coronary Disease, 1980–2000. N Engl J Med 2007; 356: 2388-2398
• 5 Münzel T, Sinning C, Post F. et al. Pathophysiology, diagnosis and prognostic implications of endothelial dysfunction. Ann Med 2008; 40: 180-196
• 6 Lerman A, Zeiher AM. Endothelial function: cardiac events. Circulation 2005; 111: 363-367
• 7 Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction: A marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 2003; 23: 168-175
• 8 Flammer AJ, Anderson T, Celermajer DS. et al. The assessment of endothelial function: from research into clinical practice. Circulation 2012; 126: 753-767
• 9 Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 228: 373-376
• 10 Hamed S, Brenner B, Roguin A. Nitric oxide: a key factor behind the dysfunctionality of endothelial progenitor cells in diabetes mellitus type-2. Cardiovasc Res 2011; 91: 9-15
• 11 Hermann M, Flammer A, Lüscher TF. et al. Nitric oxide in hypertension. J Clin Hypertens (Greenwich) 2006; 8: 17-29
• 12 Hamed S, Brenner B, Aharon A. et al. Nitric oxide and superoxide dismutase modulate endothelial progenitor cell function in type 2 diabetes mellitus. Cardiovasc Diabetol 2009; 8: 56
• 13 Ma FX, Zhou B, Chen Z. et al. Oxidized low density lipo-protein impairs endothelial progenitor cells by regulation of endothelial nitric oxide synthase. J Lipid Res 2006; 47: 1227-1237
• 14 Mancia G, Fagard R, Narkiewicz K. et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013; 34: 2159-2219
• 15 Teramoto T, Sasaki J, Ishibashi S. et al. Diagnostic criteria for dyslipidemia. J Atheroscler Thromb 2013; 20: 655-660
• 16 Committee of the Japan Diabetes Society on the Diagnostic Criteria of Diabetes Mellitus. Report of the committee on the classification and diagnostic criteria of diabetes mellitus. J Diabetes Investig 2010; 1: 212-228
• 17 Etsuda H, Takase B, Uehata A. et al. Morning attenuation of endothelium-dependent, flow-mediated dilation in healthy young men: Possible connection to morning peak of cardiac events?. Clin Cardiol 1999; 22: 417-421
• 18 Otto ME, Svatikova A, Barretto RB. et al. Early morning attenuation of endothelial function in healthy humans. Circulation 2004; 109: 2507-2510
• 19 Tochikubo O, Kawano Y, Miyajima E. et al. A newphoto-oscillometric method employing the delta-algorithm for accurate blood pressure measurement. J Hypertns 1997; 15: 147-156
• 20 Versari D, Daghini E, Virdis A. et al. Endothelium-dependent contractions and endothelial dysfunction in human hypertension. Br J Pharmacol 2009; 157: 527-536
• 21 Greig FH, Kennedy S, Spickett CM. Physiological effects of oxidized phospholipids and their cellular signaling mechanisms in inflammation. Free Radic Biol Med 2012; 52: 266-280
• 22 Tousoulis D, Papageorgiou N, Androulakis E. et al. Diabetes mellitus-associated vascular impairment: novel circulating biomarkers and therapeutic approaches. J Am Coll Cardiol 2013; 62: 667-676
• 23 Matsuzawa Y, Sugiyama S, Sumida H. et al. Peripheral endothelial function and cardiovascular events in high-risk patients. J Am Heart Assoc 2013; 2: e000426
• 24 Maeda Y, Inoguchi T, Etoh E. et al. Brachial-ankle pulse wave velocity predicts all-cause mortality and cardiovascular events in patients with diabetes: The Kyushu Prevention Study of Atherosclerosis. Diabetes Care 2014; 37: 2383-2390
• 25 Kawai T, Ohishi M, Onishi M. et al. Prognostic impact of regional arterial stiffness in hypertensive patients. Heart Vessels 2015; 30: 338-346
• 26 van der Heijden AA, Ortegon MM, Niessen LW. et al. Prediction of coronary heart disease risk in a general, pre-diabetic, and diabetic population during 10 years of follow-up: Accuracy of the Framingham, SCORE, and UKPDS risk functions: The Hoorn Study. Diabetes Care 2009; 32: 2094-2098
• 27 Thum T, Fraccarollo D, Schultheiss M. et al. Endothelial nitric oxide synthase uncoupling impairs endothelial progenitor cell mobiliz- ation and function in diabetes. Diabetes 2007; 56: 666-674
• 28 Hamed S, Brenner B, Abassi Z. et al. Hyperglycemia and oxidized-LDL exert a deleterious effect on endothelial progenitor cell migration in type 2 diabetes mellitus. Thromb Res 2010; 126: 166-174
• 29 Perticone F, Ceravolo R, Pujia A. et al. Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation 2001; 104: 191-196
• 30 Hermann M, Flammer A, Lüscher TF. Nitric oxide in hypertension. J Clin Hypertens (Greenwich) 2006; 8: 17-29
• 31 de Meirelles LR, Mendes-Ribeiro AC, Mendes MA. et al. Chronic exercise reduces platelet activation in hypertension: Upregulation of the L-arginine-nitric oxide pathway. Scand J Med Sci Sports 2009; 19: 67-74
• 32 Harrison DG. Perspective series: Nitric oxide and nitric oxide synthases. Celluar and molecular mechanisms of endothelial cell dysfunction. J Clin Invest 1997; 100: 2153-2157
• 33 Laurent S, Cockcroft J, Van Bortel L. et al. Expert consensus document on arterial stiffness: Methodological issues and clinical applications. Eur Heart J 2006; 27: 2588-2605
• 34 Sugawara J, Hayashi K, Yokoi T. et al. Brachial-ankle pulse wave velocity; an index of central arterial stiffness?. J Hum Hypertens 2005; 19: 401-406
• 35 Zieman SJ, Melenovsky V, Kass DA. Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol 2005; 25: 932-943